Carcinoid syndrome: update on the pathophysiology and treatment
Approximately 30-40% of patients with well-differentiated neuroendocrine tumors present with carcinoid syndrome, which is a paraneoplastic syndrome associated with the secretion of several humoral factors. Carcinoid syndrome significantly and negatively affects patients’ quality of life; increases c...
Main Authors: | Anezka C. Rubin de Celis Ferrari, João Glasberg, Rachel P. Riechelmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculdade de Medicina / USP
2018-08-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322018000200312&lng=en&tlng=en |
Similar Items
-
Carcinoid Syndrome and Carcinoid Heart Disease as Manifestations of Non-Metastatic Ovarian Neuroendocrine Tumour
by: Joana Simões-Pereira, et al.
Published: (2017-05-01) -
Gastrointestinal carcinoid tumors Tumores carcinoides digestivos
by: M. J. Varas Lorenzo, et al.
Published: (2010-09-01) -
Primary carcinoid tumors at atypical sites: surgery is mandatory and size determines survival—an Egyptian study
by: Karim G. Moustafa, et al.
Published: (2019-02-01) -
Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor
by: Corey A. Carter, et al.
Published: (2015-10-01) -
Primary carcinoid tumor in the external auditory canal
by: Dong Hae Chung, et al.
Published: (2020-03-01)